Floatz logo

Nifedipine

Chronic Anal Fissure

RDD Pharma LtdSmall moleculePhase 2/3Dormant
BB
67/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
53/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Chronic Anal Fissure cohort.

Asset / SponsorPhaseRating
Oxygen
Jay C. Buckey Jr.
Phase 4BB
Ven 307
Ventrus Biosciences, Inc
Phase 3NR
Glyceryl Trinitrate
Forest Laboratories
Phase 4NR

Same molecule, other indications

Nifedipine is also rated in:

diabetic kidney diseaseDormant
BB
Indicative ·
64 / 100
View asset →
focal epilepsyDormant
CCC
Indicative ·
53 / 100
View asset →
congenital adrenal hyperplasiaDormant
CCC
Indicative ·
52 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →